The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-20
DOI
10.3389/fphar.2020.00596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis
- (2019) Boru Jin et al. JOURNAL OF NEUROLOGY
- Treatment Options for Agitation in Dementia
- (2019) John M. Ringman et al. Current Treatment Options in Neurology
- Nonpharmacological Strategies Used By Family Caregivers of Persons With Alzheimer's Disease and Related Dementias as Presented in Blogs
- (2019) Joel G. Anderson et al. Journal of Gerontological Nursing
- Management of Behavioral and Psychological Symptoms of Dementia
- (2019) Laurel J. Bessey et al. Current Psychiatry Reports
- Impact of Chronic Risperidone Use on Behavior and Survival of 3xTg-AD Mice Model of Alzheimer’s Disease and Mice With Normal Aging
- (2019) Virginia Torres-Lista et al. Frontiers in Pharmacology
- The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease
- (2019) Valeria Calsolaro et al. Frontiers in Pharmacology
- Classics in Chemical Neuroscience: Risperidone
- (2018) Trevor C. Chopko et al. ACS Chemical Neuroscience
- Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
- (2018) Clive Ballard et al. LANCET NEUROLOGY
- Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus
- (2018) Helen C. Kales et al. INTERNATIONAL PSYCHOGERIATRICS
- Benefits and harms of atypical antipsychotics for agitation in adults with dementia
- (2017) Martin R. Farlow et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dementia prevention, intervention, and care
- (2017) Gill Livingston et al. LANCET
- Antipsychotic Use in Dementia
- (2016) Julia Kirkham et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
- (2016) Rajesh R. Tampi et al. Therapeutic Advances in Chronic Disease
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis
- (2014) Uli Hacksell et al. NEUROCHEMICAL RESEARCH
- Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System
- (2014) Douglas L. Leslie et al. PSYCHIATRIC SERVICES
- Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study
- (2013) Ju-Young Shin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Comparative Risk of Cerebrovascular Adverse Events in Community-Dwelling Older Adults using Risperidone, Olanzapine and Quetiapine
- (2012) Satabdi Chatterjee et al. DRUGS & AGING
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic Potential of 5-HT2CReceptor Ligands
- (2011) Nanna H. Jensen et al. TheScientificWorldJOURNAL
- The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
- (2009) Clive Ballard et al. LANCET NEUROLOGY
- Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
- (2008) Rosa Liperoti et al. Current Neuropharmacology
- Using risperidone for Alzheimer's dementia-associated psychosis
- (2008) Karleen M McNeal et al. EXPERT OPINION ON PHARMACOTHERAPY
- Beneficial and adverse effects of pharmacotherapy with risperidone on behavioral and psychological symptoms of dementia (BPSD)
- (2008) Norihito OSHIMA Psychogeriatrics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now